Section Arrow
Quote
NXL.NASDAQ
- Nexalin Technology Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/10/01 11:11 EDT
Regular Hours
Last
 7.56
+3.28 (+76.64%)
Day High 
10.98 
Prev. Close
4.28 
1-M High
7.69 
Volume 
42.42M 
Bid
7.56
Ask
7.58
Day Low
6.8 
Open
8.8 
1-M Low
4 
Market Cap 
3.55M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.54 
20-SMA 4.81 
50-SMA 8.11 
52-W High 60 
52-W Low 4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-13.80/--
Enterprise Value
3.55M
Balance Sheet
Book Value Per Share
1.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.65K
Operating Revenue Per Share
0.78
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NXLNexalin Technology Inc.7.625+3.345+78.15%-- 
QSIQuantum-Si1.333+0.263+24.58%-- 
PACBPacific Biosciences of California2.3851+0.0151+0.64%-- 
MDTMedtronic plc86.085-0.205-0.24%21.25PE
VNRXVolitionRX Limited0.2411-0.0169-6.55%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.